Welcome to AIS Health

From Specialty Pharmacy News - Although the FDA has yet to approve a product through the 351(k) biosimilar pathway, multiple follow-on drugs are working their way through the pipeline, noted Kate Keeping, senior director of biosimilars research for BioTrends Research Group at a June 30 webinar sponsored by the company. “The United States is the only developed market to have no biosimilars, but development is ramping up,” Keeping said. As of June, 23 biosimilar products were in U.S. Read more

From Health Plan Week - Recent results from a UnitedHealthcare oncology-focused bundling pilot have caught the attention of the health insurance industry by demonstrating that the model saves money for more than just procedural care, like knee replacements. Read more

From ACO Business News - Antitrust laws treat collaborations among health care providers — including accountable care organizations — differently from the way they treat price-fixing schemes. But that doesn’t mean ACOs will never merit scrutiny from the Federal Trade Commission, FTC Bureau of Competition Director Deborah Feinstein says. To date, the FTC hasn’t opposed the formation of an ACO, Feinstein told attendees at the recent National Accountable Care Organization Summit in Washington, D.C., sponsored by… Read more

From Medicare Advantage News - CMS on July 16 took another step in the move toward the start of a long-delayed Recovery Audit Contractor (RAC) program for Medicare Advantage plans, as required under the 2010 Affordable Care Act. But the issuance by the agency’s Center for Program Integrity of a Statement of Work (SOW) for the MA RAC initiative still leaves attorneys with questions about how effective the program might be and what problems it… Read more

From Drug Benefit News - Marking another key step in the long-awaited arrival of biosimilars to the U.S., Sandoz on July 24 said the FDA accepted biosimilar filgrastim for review. Sandoz, a Novartis Group company, is the first firm to announce a biosimilar filing under the pathway created in the Biologics Price Competition and Innovation Act contained in the health reform law. Read more

From Report on Patient Privacy - It sounds like something out of a 60s-era rock song. But the alleged failure of a Rhode Island medical center to keep track of more than a dozen computer back-up tapes during a “hospital-wide media destruction” has cost it a penalty of $150,000 and resulted in a corrective action plan that requires, among other things, that it hire a private firm to audit how well it is complying with HIPAA. Read more

Today from Washington

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?